COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,699 Articles (22,913 medRxiv, 8,786 bioRxiv)

Most recent first Previous |  Page 962: Articles 9611-9620  | Next

Risk of SARS-CoV-2 reinfection 18 months after primary infection: population-level observational study.
Flacco, M. E., Soldato, G., Acuti Martellucci, C., Di Martino, G., Carota, R., Caponetti, A., Manzoli, L.
10.1101/2022.02.19.22271221 — Posted: 2022-02-19
Evolutionary Trajectories of SARS-CoV-2 Alpha and Delta Variants in White-Tailed Deer in Pennsylvania
Marques, A. D., Sherrill-Mix, S., Everett, J., Adhikari, H., Reddy, S., Ellis, J. C., Zeliff, H., Greening, S. S., Cannuscio, C. C., Strelau, K. M., Collman, R. G., Kelly, B. J., Rodino, K. G., Bushman, F. D., Gagne, R. B., Anis, E.
10.1101/2022.02.17.22270679 — Posted: 2022-02-19
Host and microbiome features of secondary infections in lethal covid-19
Zacharias, M., Kashofer, K., Wurm, P., Regitnig, P., Schuette, M., Neger, M., Ehmann, S., Marsh, L. M., Kwapiszewska, G., Loibner, M., Birnhuber, A., Leitner, E., Thueringer, A., Winter, E., Sauer, S., Pollheimer, M. J., Vagena, F. R., Lackner, C., Jelusic, B., Ogilvie, L., Durdevic, M., Timmermann, B., Lehrach, H., Zatloukal, K., Gorkiewicz, G.
10.1101/2022.02.18.22270995 — Posted: 2022-02-19
Real-time monitoring of the effectiveness of six COVID-19 vaccines in Hungary in 2021 using the screening method
Horvath, K. J., Ferenci, T., Ferenczi, A., Turi, G., Rost, G., Oroszi, B.
10.1101/2022.02.18.22271179 — Posted: 2022-02-19
Steroid Treatment Balance According To The Lymphocyte / White Blood Cells Ratio In COVID-19 Patients, A Retrospective Cohort Analysis
Arslan, F., Mert, A., Bayram, M., Ankarali, H., Vahaboglu, H.
10.1101/2022.02.16.22271033 — Posted: 2022-02-19
Characterizing SARS-CoV-2 transcription of subgenomic and genomic RNAs during early human infection using multiplexed ddPCR
Hwang, H. S., Lo, C.-M., Murphy, M., Grudda, T., Gallagher, N., Luo, C. H., Robinson, M. L., Mirza, A., Conte, M., Conte, A., Zhou, R., Brooke, C. B., Pekosz, A., Mostafa, H. H., Manabe, Y. C., Thio, C. L., Balagopal, A.
10.1101/2022.02.18.22271199 — Posted: 2022-02-19
Clinical severity of Omicron sub-lineage BA.2 compared to BA.1 in South Africa
Wolter, N., JASSAT, W., DATCOV-Gen Author Group, , von Gottberg, A., Cohen, C.
10.1101/2022.02.17.22271030 — Posted: 2022-02-19 Discussion: Onsite
Genomically informed clinical comparison of three epidemic waves of COVID-19 in Malawi
Anscombe, C., Lissauer, S., Thole, H., Rylance, J., Dula, D., Menyere, M., Kutambe, B., van der Veer, C., Phiri, T., Banda, N. P., Mndolo, K. S., Mponda, K., Phiri, C., Mallewa, J., Nyirenda, M., Katha, G., Cornick, J., Mwandumba, H., Gordon, S. B., Jambo, K. C., Feasey, N., Blantyre COVID-Consortium, , Barnes, K. G., Morton, B., Ashton, P. M.
10.1101/2022.02.17.22269742 — Posted: 2022-02-19
Performance of an artificial intelligence-based smartphone app for guided reading of SARS-CoV-2 lateral-flow immunoassays
Bermejo-Pelaez, D., Marcos-Mencia, D., Alamo, E., Perez-Panizo, S., Mousa, A., Dacal, E., Lin, L., Vladimirov, A., Cuadrado, D., Mateos-Nozal, J., Galan, S., Romero-Hernandez, S., Canton, S., Luengo-Oroz, M., Rodriguez-Dominguez, S.
10.1101/2022.02.16.22271042 — Posted: 2022-02-19
Performance of three rapid antigen tests against the SARS-CoV-2 Omicron variant
Kanjilal, S., Chalise, S., Shami Shah, A., Cheng, C.-A., Senussi, Y., Uddin, R., Thiriveedhi, V., Cho, H. E., Carroll, S., Lemieux, J., Turbett, S., Walt, D. R.
10.1101/2022.02.17.22271142 — Posted: 2022-02-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).